Clusterin can also directly affect insulin signaling and inflammation, two factors that can lead to insulin resistance, via its actions on macrophage phosphoinositide 3-kinase (PI3K; a mediator of insulin signaling) and NFκB (a major pro-inflammatory pathway in insulin resistance) (118). This evidence concerns the gene NFKB1 and Insulin resistance.